Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy-Reference-Cited by-同舟云学术

Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

Published:2012 Issue:10 Volume:35 Page:576-580
ISSN:1423-0240
Container-title:Onkologie
language:en
Short-container-title:Onkologie

Author:

Kaya Ali O.,Coskun Ugur,Ozkan Metin,Sevinc Alper,Yilmaz Ahmet U.,Gumus Mahmut,Unal Olcun U.,Ozdemir Nuriye Y.,Alici Suleyman,Berk Veli,Degerli Hatice,Oner Mehmet K.,Ozturk Cemil,Kefeli Umut,Camci Celalettin

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference20 articles.

1. Cancer Statistics, 2010

2. Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

3. M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium

4. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

5. Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additive effects of resveratrol and doxorubicin on bladder cancer cells;Anti-Cancer Drugs;2021-08-27

2. Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma;Anticancer Research;2020-03

3. Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation;Tumor Biology;2015-01-08

4. Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09);Oncology;2015

5. Targeted therapies in urothelial carcinoma;Current Opinion in Oncology;2014-05